Adamed Sp. z o.o.-Product Pipeline Review-2015

Adamed Sp. z o.o.-Product Pipeline Review-2015

  • Products Id :- GMDHC07025CDB
  • |
  • Pages: 28
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Adamed Sp. z o.o.-Product Pipeline Review-2015


Global Markets Direct's, 'Adamed Sp. z o.o.-Product Pipeline Review-2015', provides an overview of the Adamed Sp. z o.o.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Adamed Sp. z o.o.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Adamed Sp. z o.o. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Adamed Sp. z o.o.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Adamed Sp. z o.o.'s pipeline products

Reasons To Buy

Evaluate Adamed Sp. z o.o.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Adamed Sp. z o.o. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Adamed Sp. z o.o.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Adamed Sp. z o.o. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Adamed Sp. z o.o.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Adamed Sp. z o.o. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Adamed Sp. z o.o. Snapshot 5

Adamed Sp. z o.o. Overview 5

Key Information 5

Key Facts 5

Adamed Sp. z o.o.-Research and Development Overview 6

Key Therapeutic Areas 6

Adamed Sp. z o.o.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Adamed Sp. z o.o.-Pipeline Products Glance 10

Adamed Sp. z o.o.-Early Stage Pipeline Products 10

Preclinical Products/Combination Treatment Modalities 10

Discovery Products/Combination Treatment Modalities 11

Adamed Sp. z o.o.-Drug Profiles 12

ADN-06 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

ADN-0965 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

ADN-1184 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

ADN-2013 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

ADN-3662 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

ADO-514 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

ADN-2157 18

Product Description 18

Mechanism of Action 18

R&D Progress 18


Product Description 19

Mechanism of Action 19

R&D Progress 19

Small Molecule for Schizophrenia 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Small Molecule to Agonize mGluR2 for Anxiety Disorders 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Small Molecule to Inhibits MDM2 and MDM4 for Cancer 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Adamed Sp. z o.o.-Pipeline Analysis 23

Adamed Sp. z o.o.-Pipeline Products by Target 23

Adamed Sp. z o.o.-Pipeline Products by Molecule Type 24

Adamed Sp. z o.o.-Pipeline Products by Mechanism of Action 25

Adamed Sp. z o.o.-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Appendix 27

Methodology 27

Coverage 27

Secondary Research 27

Primary Research 27

Expert Panel Validation 27

Contact Us 27

Disclaimer 28

List of Tables

Adamed Sp. z o.o., Key Information 5

Adamed Sp. z o.o., Key Facts 5

Adamed Sp. z o.o.-Pipeline by Indication, 2015 7

Adamed Sp. z o.o.-Pipeline by Stage of Development, 2015 8

Adamed Sp. z o.o.-Monotherapy Products in Pipeline, 2015 9

Adamed Sp. z o.o.-Preclinical, 2015 10

Adamed Sp. z o.o.-Discovery, 2015 11

Adamed Sp. z o.o.-Pipeline by Target, 2015 23

Adamed Sp. z o.o.-Pipeline by Molecule Type, 2015 24

Adamed Sp. z o.o.-Pipeline Products by Mechanism of Action, 2015 25

Adamed Sp. z o.o., Subsidiaries 26

List of Figures

Adamed Sp. z o.o.-Pipeline by Top 10 Indication, 2015 6

Adamed Sp. z o.o.-Pipeline by Stage of Development, 2015 8

Adamed Sp. z o.o.-Monotherapy Products in Pipeline, 2015 9

Adamed Sp. z o.o.-Pipeline by Top 10 Target, 2015 23

Adamed Sp. z o.o.-Pipeline by Top 10 Molecule Type, 2015 24

Adamed Sp. z o.o.-Pipeline Products by Top 10 Mechanism of Action, 2015 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of Adamed Sp. z o.o.; Adamed Sp. z o.o. - Key Therapeutics; Adamed Sp. z o.o. - Pipeline Overview and Promising Molecules; Adamed Sp. z o.o. - News; Adamed Sp. z o.o. - Latest Updates; Adamed Sp. z o.o. - Pipeline; Adamed Sp. z o.o. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101985
Site License
USD 3000 INR 203970
Corporate User License
USD 4500 INR 305955



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]